Skip to content
Screener

Constellium CSTM AS&I — Depreciation, Amortization And Impairment Charge

Other segment segments

P&ARP
$48M+6.7%
A&T
$19M+5.6%
H&C
$1M-50.0%

Similar metrics at other companies

The J.M. Smucker Company logo
SJMDepreciation, amortization, and impairment charges
$134.4M-87.8%
The J.M. Smucker Company logo
SJMOther — Depreciation, amortization, and impairment charges
$10.1M+9.8%
Orthofix Medical Inc. logo
OFIXDepreciation Amortization And Impairment
$13.27M-21.3%
Orthofix Medical Inc. logo
OFIXDepreciation Amortization And Impairment
$13.27M-21.3%
PRA Group logo
PRAADepreciation, amortization and impairment
$2.61M-3.3%
Tesla, Inc. logo
TSLADepreciation, amortization and impairment
$1.62B+13.0%

Other financials

Income statement

See full
Revenue$2.7B+30.7%
Gross profit$480.0M+82.5%
Net income$146.0M+306%
EPS (diluted)$1.04+316%

Balance sheet

See full
Cash & equivalents$163.0M+22.6%
Total debt$2.0B-10.8%
Total equity$1.2B+59.7%
Total assets$6.1B+13.1%

Cash flow

See full
Operating cash flow$161.0M+41.2%
CapEx$77.0M0.0%
Free cash flow$84.0M+127%

Valuation

See full
Market cap$3.88B+107%
Enterprise value$5.71B+43.7%
P/E7.1×
P/S0.4×+0.2×

Profitability

See full
Gross margin16.3%+4.0pp
Net margin5.7%
FCF margin2.3%+1.7pp

Returns & leverage

See full
Return on equity53.8%
Debt / equity1.6×-1.3×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by Constellium in its filing.

Tagged under the XBRL concept cstm:DepreciationAmortizationAndImpairmentCharge.

The source filing: Constellium’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 12:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001563411-26-000192
(in millions of U.S. dollars)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
A&T(19)(18)(37)(35)
P&ARP(48)(45)(95)(89)
AS&I(15)(17)(35)(33)
H&C (A)(1)(2)(3)(3)
Total depreciation, amortization and impairment expense(83)(82)(170)(160)

Item 1. Financial Statements

FAQ

What is Constellium's AS&I — depreciation, amortization and impairment charge?
Constellium (CSTM) reported AS&I — depreciation, amortization and impairment charge of $15M in Q2 2026.
How has Constellium's AS&I — depreciation, amortization and impairment charge changed year-over-year?
Constellium's AS&I — depreciation, amortization and impairment charge decreased by 11.8% year-over-year, from $17M to $15M.
What is the long-term trend for Constellium's AS&I — depreciation, amortization and impairment charge?
Over 3 years (2022 to 2025), Constellium's AS&I — depreciation, amortization and impairment charge has grown at a 1.6% compound annual growth rate (CAGR), from $84M to $88M.
What does AS&I — depreciation, amortization and impairment charge mean?
Reflects the systematic allocation of the cost of tangible and intangible assets over their useful lives, along with any recognized impairment losses. It provides insight into the aging of the asset base and potential risks to asset valuation.

Ask your AI about Constellium's as&i — depreciation, amortization and impairment charge.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude